The UK implemented its medical cannabis law in November 2018, signifying the first time patients could obtain cannabis-based medicinal products (CBMPs) without one-off exemptions. Since then however, the market has struggled to develop, with only a few hundred prescriptions being written so far.
On the other hand, the CBD wellness market in the UK is evolving rapidly, with an increasing number of high street stores stocking a wide variety of CBD products, ranging from oils and capsules to vapes, edibles and drinks.
By October 2019 there were over 1.6 million regular users of CBD products in the UK*.
*Materia UK CBD Market Segmentation Report 2019
As UK physicians become acquainted with medical cannabis’ benefits and policymakers determine how to expand patient access, Materia has developed the infrastructure to import and distribute CBMPs, in preparation for the expansion of the UK medicinal market.
In the Wellness CBD category, Materia focuses on direct-to-consumer distribution for its partner brands, as well as offering manufacturing and retail distribution through its network. This allows Materia to lead market access and expansion to brands who seek to enter the UK from all over the world. For more details on Materia Wellness, please visit our wellness section.
Materia is a founding member of the Centre for Medicinal Cannabis (CMC), which is the UK’s leading industry membership body for businesses operating in the cannabis-based medicinal product market.